WHT dexa given in acute meningitis
Reading File
Finding Sources
Searching PubMed
dexamethasone bacterial meningitis adjunctive therapy
Reading File
Reading File
Reading File
Here is a comprehensive answer on why dexamethasone is given in acute bacterial meningitis:
Why Dexamethasone is Given in Acute Bacterial Meningitis
Pathophysiological Rationale
When bactericidal antibiotics lyse bacterial cell walls, they trigger the massive release of cell-wall components (endotoxins, peptidoglycans) into the subarachnoid space (SAS). This drives the production of pro-inflammatory cytokines — IL-1β and TNF-α — by macrophages and microglia. The resulting neuroinflammation is responsible for much of the morbidity, not the bacteria themselves.
Dexamethasone counteracts this by:
- Inhibiting synthesis of IL-1β and TNF-α at the mRNA level
- Decreasing CSF outflow resistance
- Stabilizing the blood-brain barrier
Harrison's Principles of Internal Medicine 22E, 2025
Why It Must Be Given BEFORE or WITH Antibiotics
The critical pharmacological point: dexamethasone must be given 15–20 minutes before (or at the latest simultaneously with) the first antibiotic dose.
This is because dexamethasone only blocks TNF-α production before macrophages and microglia are activated by endotoxin. Once cytokine production has been triggered, dexamethasone cannot reverse it. It is unlikely to offer significant benefit if started >6 hours after antimicrobials.
Dosing
| Setting | Dose | Duration |
|---|---|---|
| Adults | 10 mg IV every 6 hours | 4 days |
| Children | 0.15 mg/kg IV every 6 hours | 2–4 days |
Clinical Evidence
- A landmark European RCT (2002) showed adjunctive dexamethasone reduced unfavorable neurologic outcomes from 25% → 15% and mortality from 15% → 7% in adults with bacterial meningitis, with the greatest benefit in pneumococcal meningitis.
- A Vietnamese trial showed ~54% reduction in death and disability at 6 months.
- Dexamethasone reduces sensorineural hearing loss (via prevention of labyrinthitis) in H. influenzae and pneumococcal meningitis.
Goldman-Cecil Medicine; Harrison's 22E
Who Benefits Most
| Organism | Benefit |
|---|---|
| S. pneumoniae | ✅ Strongest evidence — reduces mortality and neurologic sequelae |
| H. influenzae type b | ✅ Reduces hearing loss |
| N. meningitidis | ✅ Reduces death and hearing loss (but less proven for other sequelae) |
| Listeria monocytogenes | ⚠️ Uncertain/possibly harmful |
Important Caveats
-
Vancomycin penetration: Dexamethasone reduces CSF penetration of vancomycin by tightening the blood-brain barrier — the very mechanism that makes it beneficial. Therefore, vancomycin dose must be increased to 45–60 mg/kg/day when dexamethasone is co-administered, or vancomycin can be given intraventricularly.
-
Low-income countries / HIV patients: Three large RCTs in sub-Saharan Africa and Southeast Asia showed no benefit in predominantly HIV-positive populations or in patients with late presentation, malnutrition, or culture-negative disease. Dexamethasone is not recommended in these settings.
-
Children: Recommended for confirmed/suspected H. influenzae type b meningitis. Use in pneumococcal meningitis in children remains controversial. Should not be started if antibiotics have already been given.
Tintinalli's Emergency Medicine; Harrison's 22E; Goldman-Cecil Medicine
Summary
Dexamethasone is given as adjunctive anti-inflammatory therapy to blunt the cytokine storm triggered by antibiotic-induced bacterial lysis. It reduces mortality, neurologic sequelae, and sensorineural hearing loss — primarily in pneumococcal meningitis in adults in high-income countries — but only when given before or simultaneously with the first antibiotic dose.
Why vanco given
Finding Sources
Reading File
Reading File
Why Vancomycin is Given in Acute Bacterial Meningitis
The Core Reason: Drug-Resistant S. pneumoniae
Streptococcus pneumoniae is the most common and most lethal cause of bacterial meningitis in adults. The problem is the emergence of penicillin-resistant and cephalosporin-resistant strains of pneumococcus globally.
- Penicillin-resistant: MIC >0.12 μg/mL
- Cephalosporin-resistant (intermediate): MIC ≥1 μg/mL
- Cephalosporin-resistant (high): MIC ≥2 μg/mL
Third-generation cephalosporins (ceftriaxone, cefotaxime) alone cannot reliably cover drug-resistant pneumococcus. Vancomycin is the antibiotic of choice when cephalosporin MIC >1 μg/mL.
Harrison's Principles of Internal Medicine 22E
Why Not Wait for Culture Results?
Meningitis is a medical emergency — antibiotics must be started within 60 minutes of arrival, before CSF culture or sensitivity results are available. Since you cannot know at the bedside whether the pneumococcus is resistant, vancomycin is added empirically to cover the possibility.
Standard Empirical Regimen (Adults)
| Drug | Role |
|---|---|
| Ceftriaxone (or cefotaxime) | Covers susceptible S. pneumoniae, N. meningitidis, H. influenzae |
| Vancomycin | Covers drug-resistant S. pneumoniae |
| Dexamethasone | Anti-inflammatory adjunct |
| ± Ampicillin | Add if >55 years / immunocompromised → covers Listeria |
The Dexamethasone–Vancomycin Interaction (Crucial Point)
This creates a pharmacological paradox:
- Dexamethasone, by stabilizing the blood-brain barrier, reduces CSF penetration of vancomycin
- Yet both are needed simultaneously
Solution: When dexamethasone is given alongside vancomycin, the vancomycin dose must be increased to 45–60 mg/kg/day to ensure adequate CSF levels. Alternatively, intraventricular vancomycin can be used in refractory cases where IV vancomycin fails to sterilize the CSF.
De-escalation After Culture Results
Once sensitivities are known:
- If pneumococcus is penicillin-sensitive (MIC <0.06 μg/mL): switch to penicillin G or ampicillin; vancomycin can be stopped
- If cephalosporin-sensitive (MIC ≤0.5 μg/mL): ceftriaxone alone is adequate
- If resistant: continue vancomycin ± add rifampin (for synergy; rifampin cannot be used as monotherapy as resistance develops rapidly)
Also Used in Other Settings
| Indication | Reason |
|---|---|
| Hospital-acquired / post-neurosurgery meningitis | Cover MRSA and coagulase-negative staphylococci |
| Methicillin-resistant S. aureus meningitis | Drug of choice for MRSA |
| Penicillin allergy | Alternative coverage |
Harrison's 22E; Goldman-Cecil Medicine
In short: Vancomycin is added empirically because drug-resistant S. pneumoniae cannot be excluded at presentation, and cephalosporins alone are insufficient to cover resistant strains. It is the safety net against treatment failure in the most dangerous cause of bacterial meningitis.
Differential for low sugar and high protein in csf
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Differential Diagnosis: Low CSF Glucose + High CSF Protein
Normal CSF: Glucose 50–100 mg/dL, Protein 15–45 mg/dL. CSF glucose is considered low when <50 mg/dL or CSF:serum glucose ratio <0.5 (abnormal if <0.4 is highly suggestive of bacterial meningitis).
The combination of hypoglycorrhachia + elevated protein indicates significant meningeal pathology and narrows the differential considerably.
INFECTIOUS CAUSES
Bacterial
| Condition | Glucose | Protein | Cells | Notes |
|---|---|---|---|---|
| Acute bacterial meningitis | Very low (<40 mg/dL) | 100–1000 mg/dL | 100–5000, PMN predominance | CSF:serum ratio <0.4 highly suggestive |
| Tuberculous meningitis | Low (<50 mg/dL) | 100–500 mg/dL | <500, lymphocyte predominance | Fibrin web; AFB smear/culture |
| Partially treated bacterial meningitis | Low | Elevated | Mixed PMN + lymphocytes | Bacteria may be absent on Gram stain |
| Brucella meningitis | Often low | Elevated | Lymphocytic | Occupational/exposure history |
Fungal
| Condition | Glucose | Protein | Notes |
|---|---|---|---|
| Cryptococcal meningitis | Low | Elevated | India ink, cryptococcal antigen; commonest in HIV |
| Coccidioides immitis | Often low | Elevated | May have 10–20% eosinophils |
| Histoplasma capsulatum | Low | Elevated | Complement-fixing antibodies in CSF |
| Blastomyces dermatitidis | Low | Elevated | Rare CNS involvement |
| Candida meningitis | Low | Elevated | Immunocompromised host |
| Sporotrichosis | Low | 200–800 mg/dL | Very high protein |
Viral (rare exceptions)
Viral meningitis normally has normal glucose, but low glucose can occasionally occur with:
- Herpes simplex encephalitis (may be reduced)
- Mumps meningitis (rarely)
- Lymphocytic choriomeningitis virus (LCMV) (rarely)
- Echovirus (in congenital agammaglobulinemia)
Parasitic
- Trypanosomiasis (stage II — meningoencephalitis): elevated protein, elevated IgM
- Toxoplasma gondii: mild pleocytosis; usually in AIDS patients
NON-INFECTIOUS CAUSES
Neoplastic (Carcinomatous / Leptomeningeal Meningitis)
- Leptomeningeal metastases (lung, breast, stomach, pancreas, melanoma, lymphoma, leukemia): low glucose + elevated protein; cytology shows malignant cells
- Primary CNS tumors with meningeal spread: meningeal glioblastoma, sarcoma, dysgerminoma
Chemical / Inflammatory
- Subarachnoid hemorrhage: breakdown products can lower glucose
- Ruptured epidermoid cyst / craniopharyngioma: chemical meningitis — low glucose, elevated protein, intense inflammatory response
- Exogenous intrathecal injections (contrast, drugs): chemical meningitis
- CNS sarcoidosis: often low glucose, elevated protein, elevated ACE in CSF and serum
- Granulomatosis with polyangiitis (Wegener's): elevated protein
Summary: Key Discriminators
| Feature | Bacterial | TB | Fungal | Carcinomatous |
|---|---|---|---|---|
| Cell type | PMN | Lymphocyte | Lymphocyte | Lymphocyte/few |
| Glucose | Very low | Low | Low | Low–normal |
| Protein | Very high | High | High | High |
| Opening pressure | High | High | Very high | Variable |
| Special test | Gram stain / culture | AFB, ADA | India ink, CrAg | Cytology |
Mnemonic for low CSF glucose: "BaTTle FLCC"
- Bacterial meningitis
- TB meningitis
- Treated bacterial meningitis (partially)
- Fungal (Crypto, Coccidio, Histo, Candida)
- Leptomeningeal carcinomatosis
- Chemical meningitis (epidermoid rupture, intrathecal drugs)
- CNS sarcoid
Neuroanatomy through Clinical Cases 3E; Goldman-Cecil Medicine; Harrison's 22E
Create a CSF findings comparison table
Here is a comprehensive CSF Findings Comparison Table across the major meningitis/CNS infection types:
CSF Findings Comparison Table
| Parameter | Normal | Acute Bacterial Meningitis | Viral (Aseptic) Meningitis | Tuberculous Meningitis | Fungal Meningitis (Cryptococcal) | Carcinomatous Meningitis | Subarachnoid Hemorrhage |
|---|---|---|---|---|---|---|---|
| Appearance | Clear, colorless | Turbid / cloudy | Clear | Clear / slightly turbid; fibrin web | Clear | Clear / slightly turbid | Bloody → xanthochromic |
| Opening Pressure | 70–180 mm H₂O | ↑↑ (>200) | Normal / mildly ↑ | ↑↑ | ↑↑↑ (very high) | Normal / ↑ | ↑↑ |
| WBC Count | <5 cells/mm³ | 100–5000/mm³ | 10–300/mm³ | 10–500/mm³ | 20–500/mm³ | 0–few (may be normal) | Elevated (RBCs >> WBCs) |
| Predominant Cell | Lymphocytes | PMN (neutrophils) | Lymphocytes | Lymphocytes | Lymphocytes | Lymphocytes / abnormal cells | RBCs |
| Glucose (mg/dL) | 50–100 | Very low (<40) | Normal (50–100) | Low (<45) | Low | Low–normal | Normal |
| CSF:Serum Glucose Ratio | >0.6 | <0.4 | >0.6 | <0.5 | <0.5 | <0.5 | Normal |
| Protein (mg/dL) | 15–45 | ↑↑↑ (100–1000) | Mildly ↑ (50–100) | ↑↑ (100–500) | ↑↑ (50–200) | ↑ (elevated) | ↑ (xanthochromia) |
| Gram Stain | Negative | Positive in ~60–80% | Negative | Negative (AFB stain) | Negative | Negative | Negative |
| Culture | Sterile | Positive in ~80% | Viral PCR | Mycobacterial culture (slow) | Fungal culture | Negative | Negative |
| Special Tests | — | Blood culture; multiplex PCR | PCR (HSV, enterovirus) | ADA ↑; AFB smear/culture; PCR | India ink ↕; CrAg (+) | Cytology (+) malignant cells | Xanthochromia; D-dimer |
| Lactate | <2 mmol/L | ↑↑ (>4 mmol/L) | Normal / mildly ↑ | ↑ | ↑ | Variable | Variable |
| Fibrin web / clot | Absent | May form | Absent | Classic "cobweb" clot | Absent | Absent | Absent |
Key Discriminating Points
| Clue | Think |
|---|---|
| PMN pleocytosis + very low glucose + turbid | Acute bacterial meningitis |
| Lymphocytosis + normal glucose + mild ↑ protein | Viral meningitis |
| Lymphocytosis + low glucose + cobweb clot + high ADA | TB meningitis |
| Very high opening pressure + low glucose + India ink (+) | Cryptococcal meningitis |
| Low/normal WBC + low glucose + positive cytology | Carcinomatous meningitis |
| Bloody → xanthochromic + no organisms | Subarachnoid haemorrhage |
| PMN early → lymphocyte later + partially treated picture | Partially treated bacterial meningitis |
Important Caveats
- Early bacterial meningitis can mimic viral (lymphocyte predominance in first few hours)
- HSV encephalitis may have RBCs, reduced glucose, and xanthochromia — mimics SAH
- TB meningitis glucose can be extremely low (<20 mg/dL) in advanced disease
- In hyperglycaemic patients, use the CSF:serum glucose ratio (<0.5 = low) rather than absolute glucose value
- Viral meningitis exceptions with low glucose: mumps, LCMV, HSV, echovirus (agammaglobulinaemia)
Neuroanatomy through Clinical Cases 3E; Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine; Tintinalli's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.